The Many Faces of High-Risk Influenza: Best Practices for Recognition and Treatment 

Release Date: November 16, 2020 
Last Reviewed: November 13, 2020
Expiration Date: November 16, 2021
Time to Complete Activity: 1.0 hour

*This activity expired for credit on November 16, 2021 and is no longer available for credit

Faculty Presenter
William A. Fischer II, MD

Associate Professor of Medicine
Division of Pulmonary and Critical Care Medicine
Institute for Global Health and Infectious Diseases
The University of North Carolina School of Medicine
Chapel Hill, NC

Steering Committee 
Robert H. Hopkins Jr, MD

Professor of Internal Medicine and Pediatrics
Chief, Division of General Internal Medicine
University of Arkansas for Medical Sciences
College of Medicine
Little Rock, AR

Andrew T. Pavia, MD, FAAP, FIDSA
George and Esther Gross Presidential Professor
Chief, Division of Pediatric Infectious Diseases 
University of Utah
Director, Hospital Epidemiology Program
Salt Lake City, UT
This activity is provided by Paradigm Medical Communications, LLC.  

Disclosure of Commercial Support
This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Target Audience
This activity has been designed to address the educational needs of clinicians involved in the care of patients with or at risk for influenza, including those specializing in internal medicine, family medicine, hospital medicine, gynecology, emergency medicine, and critical care. It may also benefit other clinicians who are interested or involved in the care of patients with or at risk for influenza. 

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Recognize appropriate candidates for influenza treatment or prophylaxis based on guideline-recommended characteristics, without unnecessary testing
  • Individualize influenza treatment and prophylaxis plans for patients who are at risk for influenza-related complications based on the latest evidence 


  • Introduction
  • Speed Round: Is This Patient at High Risk for Influenza-Related Complications?
  • Case Studies: Diagnosis and Treatment of Influenza in High-Risk Patients                
  • Overview of Current and Emerging Data on Antiviral Therapy
  • Q&A

Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PA Continuing Education
PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. 

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Instructions for Participation 
To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the preactivity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or

There is no fee required for participation in this activity.

Hardware/Software Requirements

This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here:

Technical Support: If you have any technical problems or playback issues, email us at

In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.  Any potential conflicts have been resolved.

Steering Committee 
Robert H. Hopkins Jr, MD

Dr Hopkins has no financial relationships to disclose.

Andrew T. Pavia, MD, FAAP, FIDSA
Consultant: GlaxoSmithKline plc
Royalties: Antimicrobial Therapy Inc

Faculty Presenter
William A. Fischer II, MD

Consultant: Merck & Co, Inc; Roche
Grant/Research Support: Ridgeback Biotherapeutics LP
Other: Janssen Pharmaceuticals, Inc (Adjudication Committee); Syneos Health (Adjudication Committee)

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
Independent peer and resident/fellow reviewers have no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for use have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC’s activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC. 

Terms of Use and Privacy Policy
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at (herein referred to as “website”). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at

© 2020 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.